{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T01:20:27Z","timestamp":1774142427238,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Cognitive impairment is prevalent and often highly burdensome in people with schizophrenia. The aim of this study was to investigate if mangosteen (<jats:italic>Garcinia mangostana<\/jats:italic> Linn.) pericarp extract may be an effective intervention to improve cognitive performance in this population.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This was a secondary analysis of a larger randomized placebo-controlled trial that investigated a 24-weeks intervention of mangosteen pericarp extract supplementation in people diagnosed with schizophrenia. A subset of <jats:italic>n<\/jats:italic> = 114 participants with completed cognitive outcomes at follow up were included in this analysis. Using the Cogstate Brief Battery, the following cognitive outcomes were assessed: psychomotor function, attention, visual learning and memory (visual and working). Subgroup analyses investigated whether baseline clinical parameters (baseline cognitive functioning, illness severity and duration, depressive symptoms) moderated the relationship between mangosteen pericarp extract intervention and change in cognitive outcomes.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> There were no significant between-group changes in any cognitive outcomes assessed. Subgroup analysis based on baseline cognition and clinical characteristics did not reveal any significant between-group difference in change.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Mangosteen pericarp extract did not affect cognitive outcomes in people with schizophrenia. Further investigation regarding optimal dosing strategies for mangosteen interventions and the testing of additional cognitive domains may be warranted.<\/jats:p><jats:p><jats:bold>Trial Registration:<\/jats:bold><jats:ext-link>ANZCTR.org.au<\/jats:ext-link> identifier: ACTRN12616000859482, registered 30 June 3 2016.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.626486","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T05:53:54Z","timestamp":1623736434000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial"],"prefix":"10.3389","volume":"12","author":[{"given":"Wolfgang","family":"Marx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Skvarc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alcy","family":"Meehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyna","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seetal","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue M.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Graham","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca E.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie M.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellie","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia May","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.31887\/DCNS.2019.21.3\/amccleery","article-title":"Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations","volume":"21","author":"McCleery","year":"2019","journal-title":"Dial Clin Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1037\/0033-2909.133.5.833","article-title":"Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings","volume":"133","author":"Reichenberg","year":"2007","journal-title":"Psychol Bull."},{"key":"B3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/wps.20624","article-title":"Nonsocial and social cognition in schizophrenia: current evidence and future directions","volume":"18","author":"Green","year":"2019","journal-title":"World Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/j.2051-5545.2008.tb00142.x","article-title":"Should cognitive impairment be included in the diagnostic criteria for schizophrenia?","volume":"7","author":"Keefe","year":"2008","journal-title":"World Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41537-018-0064-6","article-title":"Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis","volume":"4","author":"Sinkeviciute","year":"2018","journal-title":"NPJ Schizophrenia."},{"key":"B6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fpsyt.2019.00115","article-title":"The therapeutic potential of mangosteen pericarp as an adjunctive therapy for bipolar disorder and schizophrenia","volume":"10","author":"Ashton","year":"2019","journal-title":"Front Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11011-017-0144-8","article-title":"Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the flinders sensitive line rat","volume":"33","author":"Oberholzer","year":"2018","journal-title":"Metab Brain Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"813672","DOI":"10.1155\/2014\/813672","article-title":"Multifunctional effects of mangosteen pericarp on cognition in C57BL\/6J and triple transgenic Alzheimer's mice","volume":"2014","author":"Huang","year":"2014","journal-title":"Evid Based Compl Altern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e85053","DOI":"10.1371\/journal.pone.0085053","article-title":"Protective effects of mangosteen extract on H 2 O 2-induced cytotoxicity in SK-N-SH cells and scopolamine-induced memory impairment in mice","volume":"8","author":"Sattayasai","year":"2013","journal-title":"PLoS ONE."},{"key":"B10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.9758\/cpn.2019.17.2.297","article-title":"Protocol and rationale: A 24-week double-blind, randomized, placebo controlled trial of the efficacy of adjunctive garcinia mangostana linn (Mangosteen) pericarp for schizophrenia","volume":"17","author":"Turner","year":"2019","journal-title":"Clin Psychopharm Neurosci."},{"key":"B11","volume-title":"The Efficacy of Garcinia mangostana L. (mangosteen) Pericarp as an Adjunctive to Second-Generation Antipsychotics for the Treatment of Schizophrenia: A Double Blind, Randomized, Placebo-Controlled Trial","author":"Laupu","year":"2014"},{"key":"B12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/arclin\/acp010","article-title":"Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex","volume":"24","author":"Maruff","year":"2009","journal-title":"Arch Clin Neuropsych."},{"key":"B13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/2050-7283-1-30","article-title":"Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease","volume":"1","author":"Maruff","year":"2013","journal-title":"BMC Psych."},{"key":"B14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/arclin\/acq008","article-title":"Deriving reliable change statistics from test\u2013retest normative data: Comparison of models and mathematical expressions","volume":"25","author":"Hinton-Bayre","year":"2010","journal-title":"Arch Clin Neuropsych."},{"key":"B15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophr Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull."},{"key":"B17","volume-title":"A New Depression Scale Designed to be Sensitive to Change","author":"Montgomery","year":"1977"},{"key":"B18","volume-title":"Statistical Power Analysis for the Behavioral Sciences, 2nd edn","author":"Cohen","year":"1988"},{"key":"B19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0706743720982437","article-title":"Adjunctive Garcinia mangostana Linn (mangosteen) pericarp for schizophrenia: a 24-week double-blind, randomised, placebo controlled efficacy trial","volume":"66","author":"Turner","year":"2020","journal-title":"Can J Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/eip.12544","article-title":"Adjunctive nutrients in first-episode psychosis: a systematic review of efficacy, tolerability and neurobiological mechanisms","volume":"12","author":"Firth","year":"2018","journal-title":"Early Interv Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fpsyt.2016.00159","article-title":"Resveratrol supplementation did not improve cognition in patients with schizophrenia: results from a randomized clinical trial","volume":"7","author":"Zortea","year":"2016","journal-title":"Frontiers in psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbi.2019.04.001","article-title":"The effect of blueberry interventions on cognitive performance and mood: a systematic review of randomized controlled trials","volume":"85","author":"Travica","year":"2019","journal-title":"Brain Behav Immunity."},{"key":"B23","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/HYPERTENSIONAHA.112.193060","article-title":"Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study","volume":"60","author":"Desideri","year":"2012","journal-title":"Hypertension."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1021\/jf050384i","article-title":"Identification of urolithin A as a metabolite produced by human colon microflora from ellagic acid and related compounds","volume":"53","author":"Cerd\u00e1","year":"2005","journal-title":"J Agricult Food Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3945\/jn.111.156992","article-title":"Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults","volume":"142","author":"Chitchumroonchokchai","year":"2012","journal-title":"J Nutr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"nuy010-nuy","DOI":"10.1093\/nutrit\/nuy010","article-title":"Effect of resveratrol supplementation on cognitive performance and mood in adults: a systematic literature review and meta-analysis of randomized controlled trials","volume":"2018","author":"Marx","year":"2018","journal-title":"Nutr Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4143\/crt.2014.46.1.2","article-title":"Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice","volume":"46","author":"Prasad","year":"2014","journal-title":"Cancer Res Treatment."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1039\/D0FO00346H","article-title":"Effects of the apple matrix on the postprandial bioavailability of flavan-3-ols and nutrigenomic response of apple polyphenols in minipigs challenged with a high fat meal","volume":"11","author":"Monfoulet","year":"2020","journal-title":"Food Funct."},{"key":"B29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof of concept study","volume":"21","author":"Rapaport","year":"2016","journal-title":"Mol Psychiatry."},{"key":"B30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/da.23025","article-title":"The effect of vitamin D supplement on negative emotions: A systematic review and meta-analysis","volume":"37","author":"Cheng","year":"2020","journal-title":"Depr Anxiety."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.schres.2004.09.010","article-title":"Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia","volume":"72","author":"Marder","year":"2004","journal-title":"Schizophr Res."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.626486\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T05:53:59Z","timestamp":1623736439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.626486\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":31,"alternative-id":["10.3389\/fpsyt.2021.626486"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.626486","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]},"article-number":"626486"}}